Byron Creese

Using neuropsychiatric symptoms as clinical markers for dementia diagnosis

Molecular processes driving psychosis in Alzheimer’s disease

Behavioral changes and dementia risk

Novel agents to treat psychosis in Alzheimer’s disease

Pharmacological vs. non-pharmacological treatment options for psychosis in AD

Assessing psychosis in Alzheimer’s disease

Mild behavioral impairment: a new clinical marker for Alzheimer’s disease?

Psychosis in patients with Alzheimer’s disease

Effect of genetics on psychosis in Alzheimer’s disease